Cargando…

Clinical significance of pancreatic calcifications: a 15-year single-center observational study

OBJECTIVES: Pancreatic calcifications (PC) are considered specific for chronic pancreatitis (CP), but PC may also be present in non-CP diseases. The aims are to understand the pattern of calcifications in different diseases and to determine they were related to malignant diseases. METHODS: A retrosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wei, Chai, Li, Zhu, Naiyi, Wang, Qingrou, Zhou, Yiran, Chai, Weimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233388/
https://www.ncbi.nlm.nih.gov/pubmed/35752857
http://dx.doi.org/10.1186/s40001-022-00725-9
_version_ 1784735754734272512
author Wang, Wei
Chai, Li
Zhu, Naiyi
Wang, Qingrou
Zhou, Yiran
Chai, Weimin
author_facet Wang, Wei
Chai, Li
Zhu, Naiyi
Wang, Qingrou
Zhou, Yiran
Chai, Weimin
author_sort Wang, Wei
collection PubMed
description OBJECTIVES: Pancreatic calcifications (PC) are considered specific for chronic pancreatitis (CP), but PC may also be present in non-CP diseases. The aims are to understand the pattern of calcifications in different diseases and to determine they were related to malignant diseases. METHODS: A retrospective study was performed including patients with PC or CP undergoing surgery in the Department of General Surgery of Ruijin Hospital from January 2003 to June 2018. RESULTS: PC were observed in 168 (4.5%) of the 3755 patients with pancreatic lesions treated during the study period. The majority of patients with PC had three kinds of CP (73.2%) while 26.8% had other five kinds of non-CP diseases. In patients with non-CP diseases, the incidence of PC in malignant intraductal papillary mucinous neoplasm (IPMN) was significantly higher than benign IPMN (8.3% vs. 0.7%, p = 0.004). In patients of CP with pancreatic mass (n = 81), PC (Odds ratio = 28.6, p = 0.000), advanced age (> 55 years) and parenchymal atrophy were independent predictors for malignancy. In patients of CP without pancreatic mass (n = 110), there were 82 cases (74.5%) with PC and 5 cases (4.5%) with pancreatic ductal adenocarcinoma. The regression model of risk factors was not successful. CONCLUSIONS: The disease spectrum with PC was very diverse. PC may be related to malignant IPMN in non-CP diseases and is related to malignancy in the patients of CP with pancreatic mass and indications for resection. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40001-022-00725-9.
format Online
Article
Text
id pubmed-9233388
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92333882022-06-26 Clinical significance of pancreatic calcifications: a 15-year single-center observational study Wang, Wei Chai, Li Zhu, Naiyi Wang, Qingrou Zhou, Yiran Chai, Weimin Eur J Med Res Research OBJECTIVES: Pancreatic calcifications (PC) are considered specific for chronic pancreatitis (CP), but PC may also be present in non-CP diseases. The aims are to understand the pattern of calcifications in different diseases and to determine they were related to malignant diseases. METHODS: A retrospective study was performed including patients with PC or CP undergoing surgery in the Department of General Surgery of Ruijin Hospital from January 2003 to June 2018. RESULTS: PC were observed in 168 (4.5%) of the 3755 patients with pancreatic lesions treated during the study period. The majority of patients with PC had three kinds of CP (73.2%) while 26.8% had other five kinds of non-CP diseases. In patients with non-CP diseases, the incidence of PC in malignant intraductal papillary mucinous neoplasm (IPMN) was significantly higher than benign IPMN (8.3% vs. 0.7%, p = 0.004). In patients of CP with pancreatic mass (n = 81), PC (Odds ratio = 28.6, p = 0.000), advanced age (> 55 years) and parenchymal atrophy were independent predictors for malignancy. In patients of CP without pancreatic mass (n = 110), there were 82 cases (74.5%) with PC and 5 cases (4.5%) with pancreatic ductal adenocarcinoma. The regression model of risk factors was not successful. CONCLUSIONS: The disease spectrum with PC was very diverse. PC may be related to malignant IPMN in non-CP diseases and is related to malignancy in the patients of CP with pancreatic mass and indications for resection. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40001-022-00725-9. BioMed Central 2022-06-25 /pmc/articles/PMC9233388/ /pubmed/35752857 http://dx.doi.org/10.1186/s40001-022-00725-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wang, Wei
Chai, Li
Zhu, Naiyi
Wang, Qingrou
Zhou, Yiran
Chai, Weimin
Clinical significance of pancreatic calcifications: a 15-year single-center observational study
title Clinical significance of pancreatic calcifications: a 15-year single-center observational study
title_full Clinical significance of pancreatic calcifications: a 15-year single-center observational study
title_fullStr Clinical significance of pancreatic calcifications: a 15-year single-center observational study
title_full_unstemmed Clinical significance of pancreatic calcifications: a 15-year single-center observational study
title_short Clinical significance of pancreatic calcifications: a 15-year single-center observational study
title_sort clinical significance of pancreatic calcifications: a 15-year single-center observational study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233388/
https://www.ncbi.nlm.nih.gov/pubmed/35752857
http://dx.doi.org/10.1186/s40001-022-00725-9
work_keys_str_mv AT wangwei clinicalsignificanceofpancreaticcalcificationsa15yearsinglecenterobservationalstudy
AT chaili clinicalsignificanceofpancreaticcalcificationsa15yearsinglecenterobservationalstudy
AT zhunaiyi clinicalsignificanceofpancreaticcalcificationsa15yearsinglecenterobservationalstudy
AT wangqingrou clinicalsignificanceofpancreaticcalcificationsa15yearsinglecenterobservationalstudy
AT zhouyiran clinicalsignificanceofpancreaticcalcificationsa15yearsinglecenterobservationalstudy
AT chaiweimin clinicalsignificanceofpancreaticcalcificationsa15yearsinglecenterobservationalstudy